Home
Conditions
Recurrent Esophageal Cancer

Clinical trial condition

Recurrent Esophageal Cancer

Explore clinical trials studying Recurrent Esophageal Cancer. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Esophageal Cancer trial results

Completed

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

NCT03461341

Conditions: Chemoradiation, Chemotherapy, Digestive System Diseases, +17 more
Locations: Department of Surgery, St. James's Hospital Dublin, Ireland

Karolinska Institutet Stockholm, Sweden

Department of Surgery and Cancer, 10th Floor, QEQM building, St. Mary's Hospital London, United Kingdom

View Trial Details

Completed

Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery

NCT01612546

Conditions: Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, +29 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer

NCT01231399

Conditions: Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, +18 more
Locations: City of Hope Medical Center Duarte, California, United States

South Pasadena Cancer Center South Pasadena, California, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

NCT01129206

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, +19 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction

NCT00077545

Conditions: Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, Digestive System Diseases, +10 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

NCT00045526

Conditions: Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, +19 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Recurrent Esophageal Cancer

Recurrent Esophageal Cancer trial results

Related conditions